Cargando…
The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation
Antigen presentation to T cells in major histocompatibility complex class II (MHC class II) requires the conversion of early endo/phagosomes into lysosomes by a process called maturation. Maturation is driven by the phosphoinositide kinase PIKfyve. Blocking PIKfyve activity by small molecule inhibit...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319320/ https://www.ncbi.nlm.nih.gov/pubmed/30612035 http://dx.doi.org/10.1016/j.isci.2018.12.015 |
_version_ | 1783385051864498176 |
---|---|
author | Baranov, Maksim V. Bianchi, Frans Schirmacher, Anastasiya van Aart, Melissa A.C. Maassen, Sjors Muntjewerff, Elke M. Dingjan, Ilse ter Beest, Martin Verdoes, Martijn Keyser, Samantha G.L. Bertozzi, Carolyn R. Diederichsen, Ulf van den Bogaart, Geert |
author_facet | Baranov, Maksim V. Bianchi, Frans Schirmacher, Anastasiya van Aart, Melissa A.C. Maassen, Sjors Muntjewerff, Elke M. Dingjan, Ilse ter Beest, Martin Verdoes, Martijn Keyser, Samantha G.L. Bertozzi, Carolyn R. Diederichsen, Ulf van den Bogaart, Geert |
author_sort | Baranov, Maksim V. |
collection | PubMed |
description | Antigen presentation to T cells in major histocompatibility complex class II (MHC class II) requires the conversion of early endo/phagosomes into lysosomes by a process called maturation. Maturation is driven by the phosphoinositide kinase PIKfyve. Blocking PIKfyve activity by small molecule inhibitors caused a delay in the conversion of phagosomes into lysosomes and in phagosomal acidification, whereas production of reactive oxygen species (ROS) increased. Elevated ROS resulted in reduced activity of cathepsin S and B, but not X, causing a proteolytic defect of MHC class II chaperone invariant chain Ii processing. We developed a novel universal MHC class II presentation assay based on a bio-orthogonal “clickable” antigen and showed that MHC class II presentation was disrupted by the inhibition of PIKfyve, which in turn resulted in reduced activation of CD4(+) T cells. Our results demonstrate a key role of PIKfyve in the processing and presentation of antigens, which should be taken into consideration when targeting PIKfyve in autoimmune disease and cancer. |
format | Online Article Text |
id | pubmed-6319320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-63193202019-01-09 The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation Baranov, Maksim V. Bianchi, Frans Schirmacher, Anastasiya van Aart, Melissa A.C. Maassen, Sjors Muntjewerff, Elke M. Dingjan, Ilse ter Beest, Martin Verdoes, Martijn Keyser, Samantha G.L. Bertozzi, Carolyn R. Diederichsen, Ulf van den Bogaart, Geert iScience Article Antigen presentation to T cells in major histocompatibility complex class II (MHC class II) requires the conversion of early endo/phagosomes into lysosomes by a process called maturation. Maturation is driven by the phosphoinositide kinase PIKfyve. Blocking PIKfyve activity by small molecule inhibitors caused a delay in the conversion of phagosomes into lysosomes and in phagosomal acidification, whereas production of reactive oxygen species (ROS) increased. Elevated ROS resulted in reduced activity of cathepsin S and B, but not X, causing a proteolytic defect of MHC class II chaperone invariant chain Ii processing. We developed a novel universal MHC class II presentation assay based on a bio-orthogonal “clickable” antigen and showed that MHC class II presentation was disrupted by the inhibition of PIKfyve, which in turn resulted in reduced activation of CD4(+) T cells. Our results demonstrate a key role of PIKfyve in the processing and presentation of antigens, which should be taken into consideration when targeting PIKfyve in autoimmune disease and cancer. Elsevier 2018-12-20 /pmc/articles/PMC6319320/ /pubmed/30612035 http://dx.doi.org/10.1016/j.isci.2018.12.015 Text en © 2018 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Baranov, Maksim V. Bianchi, Frans Schirmacher, Anastasiya van Aart, Melissa A.C. Maassen, Sjors Muntjewerff, Elke M. Dingjan, Ilse ter Beest, Martin Verdoes, Martijn Keyser, Samantha G.L. Bertozzi, Carolyn R. Diederichsen, Ulf van den Bogaart, Geert The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation |
title | The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation |
title_full | The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation |
title_fullStr | The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation |
title_full_unstemmed | The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation |
title_short | The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation |
title_sort | phosphoinositide kinase pikfyve promotes cathepsin-s-mediated major histocompatibility complex class ii antigen presentation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319320/ https://www.ncbi.nlm.nih.gov/pubmed/30612035 http://dx.doi.org/10.1016/j.isci.2018.12.015 |
work_keys_str_mv | AT baranovmaksimv thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT bianchifrans thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT schirmacheranastasiya thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT vanaartmelissaac thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT maassensjors thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT muntjewerffelkem thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT dingjanilse thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT terbeestmartin thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT verdoesmartijn thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT keysersamanthagl thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT bertozzicarolynr thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT diederichsenulf thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT vandenbogaartgeert thephosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT baranovmaksimv phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT bianchifrans phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT schirmacheranastasiya phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT vanaartmelissaac phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT maassensjors phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT muntjewerffelkem phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT dingjanilse phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT terbeestmartin phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT verdoesmartijn phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT keysersamanthagl phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT bertozzicarolynr phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT diederichsenulf phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation AT vandenbogaartgeert phosphoinositidekinasepikfyvepromotescathepsinsmediatedmajorhistocompatibilitycomplexclassiiantigenpresentation |